Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
VANCOUVER, British Columbia, Oct. 27, 2021 (GLOBE NEWSWIRE) -- Ameriwest Lithium Inc. (“Ameriwest” or the “Company”) (CSE: AWLI) (OTC: AWLIF) (FSE: 5HV0), a North American lithium exploration and...
-
VANCOUVER, British Columbia, Oct. 27, 2021 (GLOBE NEWSWIRE) -- Nabati Foods Global Inc. (CSE: MEAL) (FSE:7UW) (“Nabati Foods” or the “Company”), a plant-based food technology company offering whole,...
-
Focus on expanding the delivery of controlled-substances in a microneedle patch.Evaluating potential uses of a microneedle patch for infectious diseases.Strengthening capabilities in the manufacturing...
-
Calcination, Acid Roasting and Water Leaching of spodumene concentrate (reported October 12, 2021) to produce lithium carbonate Higher than 99% pure lithium carbonate achieved Approximately 99% Li2O...
-
VANCOUVER, British Columbia, Oct. 27, 2021 (GLOBE NEWSWIRE) -- ParcelPal Logistics Inc. (the “Company” or “ParcelPal”), (OTC:PTNYF) (CSE:PKG) (FSE:PT0) is pleased to announce that is has published...
-
Further strengthens the Company’s drug development pipeline of tryptamines by introducing novel psilocin analogues containing enhancements in safety and efficacy tailored for medical use DENVER, Oct....
-
Philadelphia, PA, Oct. 27, 2021 (GLOBE NEWSWIRE) -- VSBLTY Groupe Technologies Corp. (OTCQB: VSBGF) (CSE:VSBY) (Frankfurt 5VS) (“VSBLTY”), a leading software provider of security and retail...
-
VANCOUVER, British Columbia, Oct. 27, 2021 (GLOBE NEWSWIRE) -- Irwin Naturals Inc. (CSE: IWIN) (FRA: 97X) (“Irwin” or the “Company”), a household name and best-in-class herbal supplement formulator...
-
VANCOUVER, BC CANADA, Oct. 27, 2021 (GLOBE NEWSWIRE) -- LOVE Pharma Co. (CSE: LUV) (FSE: G1Q0), the Company is pleased to announce the debut of its first two products, BLOOM™ and AURALIEF™. ...
-
--Evolving Pipeline of Psychedelics Compounds Focused on Improved Efficacy and Safety Advancing MSP-1014 as First Lead Drug Clinical Candidate to IND-Enabling Studies Developing...